Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “t-cell”

88 pharma patents match "t-cell" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 88
Index total 30,257
Page 2 / 4

Quick answer

This filtered view shows 88 pharmaceutical patents matching "t-cell" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

88 results for “t-cell” · 30,257 patents in full index Clear search

  1. US 11885806

    Method for depleting malignant T-cells

    AUTOLUS LIMITED · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  2. US 11878062

    Multimeric T-cell modulatory polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  3. US 11879003

    Methods for increasing T-cell function

    Kyverna Therapeutics, Inc. · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  4. US 11851672

    CAR T-cells comprising transcriptional circuits

    AUTOLUS LIMITED · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  5. US 11851467

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  6. US 11850264

    Gamma delta T-cell receptor and its ligand

    University College Cardiff Consultants Limited · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  7. US 11851471

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  8. US 11786582

    Human application of engineered chimeric antigen receptor (CAR) T-cells

    The Board of Regents of the University of Texas System · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted
  9. US 11739133

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  10. US 11725039

    α/β t-cell receptor and methods of using it

    University College Cardiff Consultants Limited · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  11. US 11713446

    Processes for generating TIL products enriched for tumor antigen-specific T-cells

    Iovance Biotherapeutics, Inc. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  12. US 11708400

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  13. US 11702461

    T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory polypeptides

    Cue Biopharma, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  14. US 11603519

    T-cell receptor

    Takeda Pharmaceutical Company Limited · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted
  15. US 11597773

    CD6 antibody for treatment of T-cell mediated diseases or disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  16. US 11548945

    T-cell receptor (TCR)-binding antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  17. US 11530248

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  18. US 11505588

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  19. US 11505591

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  20. US 11401314

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  21. US 11401306

    HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof

    PDS Biotechnology Corporation · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  22. US 11385233

    Methods of depleting malignant T-cells

    AUTOLUS LIMITED · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted
  23. US 11377478

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted
  24. US 11370821

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted